-+ 0.00%
-+ 0.00%
-+ 0.00%

Tiziana Life Sciences Submits Seventh Annual Development Safety Update Report For Foralumab To FDA

Benzinga·12/29/2025 13:04:03
Listen to the news
  • Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposure